Procter & Gamble Health
₹4,709.9
-28.9 (-0.61%)
29 March, 2024 01:36 BSE: 500126
NSE: PGHLISIN: INE199A01012
Start SIP in Procter & Gamble Health
Start SIPProcter & Gamble Health Performance
Day Range
- Low 4,698
- High 4,785
52 Week Range
- Low 4,493
- High 5,643
- Open Price4,739
- Previous Close4,739
- Volume72052
Procter & Gamble Health Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 310 | 305 | 301 | 321 |
Operating Expenses Qtr Cr | 208 | 216 | 256 | 243 |
Operating Profit Qtr Cr | 102 | 89 | 45 | 80 |
Depreciation Qtr Cr | 7 | 6 | 6 | 6 |
Interest Qtr Cr | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 28 | 22 | 14 | 19 |
Net Profit Qtr Cr | 72 | 66 | 30 | 59 |
Procter & Gamble Health Technicals
EMA & SMA
Current Price
₹4,709.9
-28.9 (-0.61%)
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹4,923.01
- 50 Day
- ₹5,030.20
- 100 Day
- ₹5,065.04
- 200 Day
- ₹5,025.64
- 20 Day
- ₹4,958.28
- 50 Day
- ₹5,110.22
- 100 Day
- ₹5,092.06
- 200 Day
- ₹5,107.35
Procter & Gamble Health Resistance and Support
PIVOT
₹4,731.
Resistance | |
---|---|
First Resistance | 4,763.90 |
Second Resistance | 4,817.90 |
Third Resistance | 4,850.80 |
RSI | 28.60 |
MFI | 12.31 |
MACD Single Line | -79.00 |
MACD | -100.27 |
Support | |
---|---|
First Resistance | 4,677.00 |
Second Resistance | 4,644.10 |
Third Resistance | 4,590.10 |
Procter & Gamble Health Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 73,024 | 6,691,189 | 91.63 |
Week | 60,310 | 5,371,812 | 89.07 |
1 Month | 25,233 | 2,147,040 | 85.09 |
6 Month | 16,453 | 1,194,679 | 72.61 |
Procter & Gamble Health Result Highlights
Procter & Gamble Health Synopsis
NSE-Medical-Generic Drugs
P&G Health is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1229.62 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 30/06/2023. Procter & Gamble Health Ltd. is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726.Market Cap | 7,811 |
Sales | 1,237 |
Shares in Float | 0.80 |
No of funds | 136 |
Yield | 2.11 |
Book Value | 10.48 |
U/D Vol ratio | 0.7 |
LTDebt / Equity | |
Alpha | -0.03 |
Beta | 0.19 |
Procter & Gamble Health
Owner Name | Dec-23 | Sep-23 | Jun-23 | Mar-23 |
---|---|---|---|---|
Promoters | 51.82% | 51.82% | 51.82% | 51.82% |
Mutual Funds | 8.98% | 8.41% | 8.1% | 7.34% |
Insurance Companies | 3.41% | 3.71% | 4.08% | 4.87% |
Foreign Portfolio Investors | 7.6% | 7.38% | 7.15% | 6.72% |
Financial Institutions/ Banks | ||||
Individual Investors | 22.9% | 23.44% | 23.64% | 24.09% |
Others | 5.29% | 5.24% | 5.21% | 5.16% |
Procter & Gamble Health Management
Name | Designation |
---|---|
Mr. Suresh Talwar | Chairman & Ind.Director |
Mr. Milind Thatte | Managing Director |
Mr. Lokesh Chandak | Executive Director & CFO |
Ms. Seema Sambasivan | Non Executive Director |
Mr. Aalok Agrawal | Non Executive Director |
Mrs. Rani Jadhav | Independent Director |
Mr. S Madhavan | Independent Director |
Procter & Gamble Health Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Procter & Gamble Health Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-02-06 | Quarterly Results & Interim Dividend | |
2023-11-03 | Quarterly Results | |
2023-08-23 | Audited Results & Final Dividend | |
2023-05-15 | Quarterly Results | |
2023-02-05 | Quarterly Results & Interim Dividend |
Date | Purpose | Remarks |
---|---|---|
2024-02-14 | INTERIM | Rs.50.00 per share(500%)Interim Dividend |
2024-02-14 | SPECIAL | Rs.150.00 per share(1500%)Special Dividend |
2023-02-13 | INTERIM | Rs.45.00 per share(450%)Interim Dividend |
2022-05-13 | INTERIM | Rs.41.00 per share(410%)Interim Dividend |
Procter & Gamble Health FAQs
What is Share Price of Procter & Gamble Health ?
Procter & Gamble Health share price is ₹4,709 As on 29 March, 2024 | 01:22
What is the Market Cap of Procter & Gamble Health ?
The Market Cap of Procter & Gamble Health is ₹7818.2 Cr As on 29 March, 2024 | 01:22
What is the P/E ratio of Procter & Gamble Health ?
The P/E ratio of Procter & Gamble Health is 34.5 As on 29 March, 2024 | 01:22
What is the PB ratio of Procter & Gamble Health ?
The PB ratio of Procter & Gamble Health is 10.4 As on 29 March, 2024 | 01:22